EROAD (ERD) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
12 Jan, 2026Executive summary
Revenue for H1 FY25 rose 8% year-over-year to NZD 95.9 million, driven by unit growth, price increases, and strong progress in all key markets.
EBIT improved to NZD 2.4 million from NZD 0.1 million, reflecting operational efficiency, cost control, and positive unit growth.
Consistently positive free cash flow, with normalized free cash flow of NZD 6.2 million after adjusting for 4G hardware upgrades.
Annual recurring revenue (ARR) reached nearly NZD 178 million, up 8% in constant currency terms, with gains across all regions.
Strategic focus on product innovation, fleet growth, partnerships (notably with Geotab), and data-driven expansion into light commercial vehicles.
Financial highlights
Revenue: NZD 95.9 million, up 8% year-over-year; EBITDA rose to NZD 29.2 million from NZD 25.6 million.
EBIT: NZD 2.4 million, up from NZD 0.1 million; normalized EBIT (excluding 4G upgrade) at NZD 4.7 million.
Net loss after tax was NZD 1.5 million, similar to prior period; basic and diluted loss per share improved.
Operating costs reduced to 69% of revenue, reflecting successful cost-out initiatives.
R&D spend at NZD 16.5 million (17% of revenue), focused on AI safety, decarbonization, and product expansion.
Outlook and guidance
On track to meet FY25 guidance: revenue NZD 190–195 million, normalized EBIT NZD 5–10 million, and positive free cash flow.
Confident in achieving FY26 targets, underpinned by price increases, new product momentum, and enterprise customer expansion.
R&D spend expected to trend back to 13–15% of revenue by FY26 after current step-up.
Anticipate increased free cash flow as 4G upgrade program completes by end of 2025.
Focus on North American customer base expansion, continued NZ growth, and Australian enterprise momentum.
Latest events from EROAD
- Double-digit growth, positive cash flow, and AI innovation drive global expansion.ERD
AGM 20243 Feb 2026 - Revenue, EBIT, and cash flow exceeded guidance; strong outlook with enterprise-led growth.ERD
H2 202526 Nov 2025 - Revenue and ARR up, strong cash flow, but North American impairment drives net loss.ERD
H1 202621 Nov 2025 - Profitability returned, revenue and ARR rose, and growth-focused guidance was set for FY26.ERD
AGM 20258 Nov 2025